These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12394779)

  • 1. Proceedings of a workshop on metabolic disorders in the pathogenesis of nervous system damage in HIV-infected drug abusers. 28-29 September 1999.
    Royal W; Khalsa JH; Francis H
    J Acquir Immune Defic Syndr; 2002 Oct; 31 Suppl 2(Suppl 2):S27-93. PubMed ID: 12394779
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic, endocrine, and gastrointestinal (MEG) disorders in drug abuse and HIV/AIDS. Proceedings of a workshop. August 3-4, 1998.
    Khalsa JH; Genser S; Marriott B; Francis H
    J Acquir Immune Defic Syndr; 2000 Oct; 25 Suppl 1():S1-91. PubMed ID: 11126420
    [No Abstract]   [Full Text] [Related]  

  • 3. Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use. Proceedings of a workshop. 26-27 November 2001.
    Clin Infect Dis; 2003; 37 Suppl 2():S37-153. PubMed ID: 14569966
    [No Abstract]   [Full Text] [Related]  

  • 4. Dietary intake and body mass index in HIV-positive and HIV-negative drug abusers of Hispanic ethnicity.
    Forrester JE; Tucker KL; Gorbach SL
    Public Health Nutr; 2004 Oct; 7(7):863-70. PubMed ID: 15482611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of coma].
    Harlay A
    Infirm Fr; 1975 Nov; (169):5-7. PubMed ID: 1043821
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV/hepatitis C virus co-infection: basic, behavioral and clinical research in mental health and drug abuse.
    Joseph J; Stoff DM; van der Horst C
    AIDS; 2005 Oct; 19 Suppl 3():S3-7. PubMed ID: 16251825
    [No Abstract]   [Full Text] [Related]  

  • 7. Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use.
    Khalsa JH; Genser S; Coates P; Francis H
    Clin Infect Dis; 2003; 37 Suppl 2():S37-42. PubMed ID: 12942372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A look at nutrition and the HIV-positive substance abuser.
    Bouvier G
    HIV Clin; 2004; 16(1):15. PubMed ID: 15052991
    [No Abstract]   [Full Text] [Related]  

  • 9. Residential detoxification for substance abusers with HIV/AIDS. Walden House Detoxification Program.
    Sargent R; Sorensen JL; Greenberg B; Evans G; Acampora AP
    J Subst Abuse Treat; 1999 Jan; 16(1):87-95. PubMed ID: 9888126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug abusers and sexually transmissible disorders].
    van den Hoek JA
    Ned Tijdschr Geneeskd; 1995 Dec; 139(50):2626-9. PubMed ID: 8544886
    [No Abstract]   [Full Text] [Related]  

  • 11. Adherence to complex combination antiretroviral therapies by HIV-positive drug abusers.
    Malow RM; Baker SM; Klimas N; Antoni MH; Schneiderman N; Penedo FJ; Ziskind D; Page B; McMahon R
    Psychiatr Serv; 1998 Aug; 49(8):1021-2, 1024. PubMed ID: 9712205
    [No Abstract]   [Full Text] [Related]  

  • 12. Assess, refer, and treat: keys for substance abusers.
    Clements A; Gerse M; Gourevitch M; Havens J; Mabry SH; Masci J; Haikalis S; Rotheram-Borus MJ
    AIDS Alert; 2001 Jul; 16(7):83-6. PubMed ID: 11548651
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurological damage mediated by cytokines.
    Munno I; Pellegrino NM; Marcuccio C; Conrotto L; Jirillo E; Covelli V
    Acta Neurol (Napoli); 1992 Apr; 14(2):81-9. PubMed ID: 1414560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case management of substance abusers with HIV disease.
    Schwartz B; Dilley J; Sorensen JL
    J Case Manag; 1994; 3(4):173-8. PubMed ID: 7735090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopause-associated metabolic manifestations and symptomatology in HIV infection: a brief review with research implications.
    Looby SE
    J Assoc Nurses AIDS Care; 2012; 23(3):195-203. PubMed ID: 21924646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing neurobehavioral changes in HIV+ infants and children. A methodological approach.
    Fennell EB
    Ann N Y Acad Sci; 1993 Oct; 693():141-50. PubMed ID: 8267259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
    Celentano DD; Lucas G
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance of efavirenz-induced central nervous system side effects in HIV-infected individuals with a history of substance abuse.
    Juethner SN; Seyfried W; Aberg JA
    HIV Clin Trials; 2003; 4(3):145-9. PubMed ID: 12815554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobehavioural consequences of substance abuse and HIV infection.
    Basso MR; Bornstein RA
    J Psychopharmacol; 2000; 14(3):228-37. PubMed ID: 11106301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving treatment adherence in drug abusers who are HIV-positive.
    Malone SB; Osborne JJ
    Lippincotts Case Manag; 2000; 5(6):236-45; quiz 245-7. PubMed ID: 16398004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.